Trilo Therapeutics
Manufacturing · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2723 Monserat Ave, Belmont, California, ...Phone Number
(617) 921-1850Website
www.trilotherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Trilo Therapeutics
Trilo Therapeutics specializes in innovative cancer treatments through its Trilomer platform, which utilizes mirror-image cyclic peptides for targeted delivery of chemotherapy drugs. Their unique drug-conjugates, made from 100% D-amino acids, offer rapid tumor penetration and reduced toxicity compared to traditional antibody-drug conjugates. The company aims to address the challenges of drug delivery in cancer therapy by leveraging a proprietary DNA-encoded library that allows for the rapid discovery of millions of compounds. Their intended clients include healthcare providers and researchers focused on developing effective treatments for difficult-to-treat cancers.Explore more
Trilo Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Trilo Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Trilo Therapeutics has new funding data
Product Launch: Get notified when Trilo Therapeutics launches new products
Trilo Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Trilo Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Check if Trilo Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Trilo Therapeutics
Earning: See what the market has to say on Trilo Therapeutics recently announced quarterly report
Click to see if Trilo Therapeutics had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Trilo Therapeutics
Find 3 more new buyers
Compare Similar Companies to Trilo Therapeutics
Compare insights from companies similar to Trilo Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Trilo Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Trilo Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Trilo Therapeutics.
Trilo Therapeutics financials insights
Gather financial insights about Trilo Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$46K
Trilo Therapeutics Tech Stack
A closer look at the technologies used by Trilo Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Trilo Therapeutics
Sign Up For FreeTo access detailed company insights
Trilo Therapeutics specializes in innovative cancer treatments through its Trilomer platform, which utilizes mirror-image cyclic peptides for targeted delivery of chemotherapy drugs. Their unique drug-conjugates, made from 100% D-amino acids, offer rapid tumor penetration and reduced toxicity compared to traditional antibody-drug conjugates. The co... Read More
